Condition
    Effectiveness 1/5

    Lutein for Cataracts

    Lutein makes intuitive sense for the eye, but the lens is not the macula. AREDS tested antioxidants specifically for cataract prevention and found no effect, and no trial shows lutein slows or reverses cataracts. Dietary lutein remains worthwhile for retinal health, but established cataracts need surgery.

    Overview

    Lutein makes intuitive sense for the eye, but the lens is not the macula. AREDS tested antioxidants specifically for cataract prevention and found no effect, and no trial shows lutein slows or reverses cataracts. Dietary lutein remains worthwhile for retinal health, but established cataracts need surgery.

    Verdict

    Insufficient evidence

    AREDS tested antioxidant prevention and found no cataract benefit; no trial supports lutein for cataracts.

    How It Works

    Lutein concentrates in the macula, not the lens, and while its antioxidant properties are relevant to lens crystallin oxidation in theory, the protein damage in established cataracts is structural and irreversible.

    Dosing & Protocol

    Typical dose

    Recommended dose
    No dose is supported for cataracts. Dietary lutein from leafy greens and eggs remains sensible for overall eye health.
    Expected timeframe
    Not applicable — no demonstrated effect at any duration.

    Protocol

    form
    Not applicable
    duration
    Not applicable
    co factor
    Evidence is insufficient: AREDS2 tested 10 mg lutein with 2 mg zeaxanthin daily for five years and found no reduction in cataract progression or cataract surgery. Do not adopt a regimen for this indication - cataract is treated surgically.
    titration
    Not applicable
    starting dose
    Not applicable

    Evidence

    What the studies say

    AREDS and AREDS2 both failed to show any effect of antioxidant supplementation on cataract development or progression across thousands of participants. Observational studies link higher dietary lutein to lower cataract risk, but that association has never replicated in supplementation trials. N-acetylcarnosine drops marketed for cataracts lack credible evidence.

    Lutein/zeaxanthin for the treatment of age-related cataract: AREDS2 randomized trial report no. 4

    Score: 9/10
    2013
    rct
    n=4203

    Chew EY, SanGiovanni JP, Ferris FL +2 more

    Participants were randomly assigned to daily placebo; lutein/zeaxanthin, 10mg/2mg; omega-3 long-chain polyunsaturated fatty acids, 1 g; or a combination.

    View source

    Lutein and zeaxanthin for the prevention of age-related cataract

    Score: 9/10
    2012
    systematic_review
    n=117314

    Mathew MC, Ervin AM, Tao J +1 more

    There is no evidence from randomised trials that antioxidant or carotenoid supplementation prevents or slows age-related cataract.

    View source

    Safety

    Caveats

    The risk is delay: waiting on supplements while vision declines postpones a 20-minute operation with excellent outcomes. Any product claiming to dissolve cataracts should be treated as marketing, not medicine.

    Less likely to help if

    Everyone with an established cataract — there is no responder group because there is no demonstrated response.

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.